First Time Loading...
G

Glenmark Life Sciences Ltd
NSE:GLS

Watchlist Manager
Glenmark Life Sciences Ltd
NSE:GLS
Watchlist
Price: 805.7 INR -1.14% Market Closed
Updated: Apr 29, 2024

Glenmark Life Sciences Ltd
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Glenmark Life Sciences Ltd
Cash from Investing Activities Peer Comparison

Comparables:
DRREDDY
CIPLA
SUNPHARMA
ZYDUSLIFE
M
MANKIND

Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
G
Glenmark Life Sciences Ltd
NSE:GLS
Cash from Investing Activities
-₹1.5B
CAGR 3-Years
-45%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Cash from Investing Activities
-₹54.9B
CAGR 3-Years
-48%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Cash from Investing Activities
-₹25.1B
CAGR 3-Years
-6%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Cash from Investing Activities
-₹55.9B
CAGR 3-Years
-61%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
Cash from Investing Activities
₹10B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
M
Mankind Pharma Ltd
NSE:MANKIND
Cash from Investing Activities
-₹10.5B
CAGR 3-Years
-34%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Glenmark Life Sciences Ltd's Cash from Investing Activities?
Cash from Investing Activities
-1.5B INR

Based on the financial report for Mar 31, 2023, Glenmark Life Sciences Ltd's Cash from Investing Activities amounts to -1.5B INR.

What is Glenmark Life Sciences Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 3Y
-45%

Over the last year, the Cash from Investing Activities growth was -26%. The average annual Cash from Investing Activities growth rates for Glenmark Life Sciences Ltd have been -45% over the past three years .